Cmax
Showing 1 - 25 of >10,000
Idiopathic Pulmonary Fibrosis Trial in Adelaide (SRN-001, Placebo)
Not yet recruiting
- Idiopathic Pulmonary Fibrosis
- SRN-001
- Placebo
-
Adelaide, South Australia, AustraliaCMAX Clinical Research
Aug 2, 2023
Healthy Trial in Adelaide (XH-S003 (A), Placebo (B))
Not yet recruiting
- Healthy
- XH-S003 (A)
- Placebo (B)
-
Adelaide, South Australia, AustraliaCMAX Clinical Research
Jul 21, 2023
Postpartum Depression Trial in Adelaide (BRII-297, Placebo)
Not yet recruiting
- Postpartum Depression
- BRII-297
- Placebo
-
Adelaide, South Australia, AustraliaCMAX
May 3, 2023
Pulmonary Arterial Hypertension Trial in Adelaide (L608 Inhalation Solution, Placebo solution)
Not yet recruiting
- Pulmonary Arterial Hypertension
- L608 Inhalation Solution
- Placebo solution
-
Adelaide, South Australia, AustraliaCMAX Clinical Research Pty Ltd
Jul 12, 2023
Healthy Volunteers Trial in Adelaide (SNP318 (A), Placebo (B))
Recruiting
- Healthy Volunteers
- SNP318 (A)
- Placebo (B)
-
Adelaide, South Australia, AustraliaCMAX Clinical Research
Mar 28, 2023
Infectious Diseases, Bacterial Infections Trial in Adelaide (BWC0977, Placebo)
Not yet recruiting
- Infectious Diseases
- Bacterial Infections
- BWC0977
- Placebo
-
Adelaide, South Australia, AustraliaCMAX Clinical Research
Jul 12, 2023
Ischemia-reperfusion Injury Trial in Adelaide (BX-001N Part 1, BX-001N Part 2, Placebo)
Not yet recruiting
- Ischemia-reperfusion Injury
- BX-001N Part 1
- +2 more
-
Adelaide, South Australia, AustraliaCMAX Clinical Research
Oct 19, 2023
BK Virus Nephropathy Trial in Adelaide (AntiBKV, Placebo)
Active, not recruiting
- BK Virus Nephropathy
- AntiBKV
- Placebo
-
Adelaide, South Australia, AustraliaCMAX Clinical Research Pty Ltd
Jan 3, 2023
Still's Disease, Adult-Onset Trial in Adelaide (APB-R3, Placebo)
Not yet recruiting
- Still's Disease, Adult-Onset
- APB-R3
- Placebo
-
Adelaide, South Australia, AustraliaCMAX Clinical Research
Jan 27, 2023
Allergic Conjunctivitis Trial in Adelaide (MDI-1228_mesylate Ophthalmic Solution, Placebo)
Recruiting
- Allergic Conjunctivitis
- MDI-1228_mesylate Ophthalmic Solution
- Placebo
-
Adelaide, South Australia, AustraliaCMAX Clinical Research
Jul 24, 2023
Pneumococcal Infections Trial in Adelaide (Gamma-PN3, Prevenar-13, Pneumovax-23)
Recruiting
- Pneumococcal Infections
- Gamma-PN3
- +3 more
-
Adelaide, South Australia, AustraliaCMAX
Dec 29, 2022
Anaphylactic Reaction Trial in Adelaide (Epinephrine, Placebo)
Not yet recruiting
- Anaphylactic Reaction
- Epinephrine
- Placebo
-
Adelaide, South Australia, AustraliaCMAX Clinical Research
Aug 22, 2023
Hereditary Angioedema Trial in Adelaide (ADX-324, Placebo)
Recruiting
- Hereditary Angioedema
- ADX-324
- Placebo
-
Adelaide, South Australia, AustraliaCMAX Clinical Research
Jan 10, 2023
IBD, Crohn Disease, Ulcerative Colitis Trial in Adelaide (ATH-063, Placebo)
Recruiting
- Inflammatory Bowel Diseases
- +3 more
- ATH-063
- Placebo
-
Adelaide, South Australia, AustraliaCMAX Clinical Research
Apr 10, 2023
Bacterial Infections Trial in Adelaide (QPX2015, Placebo oral capsule)
Completed
- Bacterial Infections
- QPX2015
- Placebo oral capsule
-
Adelaide, South Australia, AustraliaCMAX
Oct 6, 2022
Interstitial Lung Disease, Chronic Kidney Diseases Trial in Adelaide (AD-214, Placebo)
Not yet recruiting
- Interstitial Lung Disease
- Chronic Kidney Diseases
- AD-214
- Placebo
-
Adelaide, South Australia, AustraliaCMAX Clinical Research Pty Ltd
Jun 20, 2023
Respiratory Syncytial Virus Infections Trial in Adelaide (Recombinant Respiratory Syncytial Virus Vaccine (BARS13) /,
Active, not recruiting
- Respiratory Syncytial Virus Infections
- Recombinant Respiratory Syncytial Virus Vaccine (BARS13) /placebo
- +2 more
-
Herston, Queensland, Australia
- +1 more
Feb 1, 2023
Elevated Low-Density Lipoprotein Cholesterol Trial in Herston, Adelaide, Melbourne (SNK-396 - SAD cohort, SNK-396 - MAD Cohort)
Recruiting
- Elevated Low-Density Lipoprotein Cholesterol
- SNK-396 - SAD cohort
- SNK-396 - MAD Cohort
-
Herston, Queensland, Australia
- +2 more
Jun 6, 2023
Healthy Trial in Adelaide (TR-01-XRR (1), TR-01-XRR (2), TR-01-XRR (3))
Not yet recruiting
- Healthy
- TR-01-XRR (1)
- +6 more
-
Adelaide, South Australia, AustraliaCMAX Clinical Research
Feb 3, 2023
Healthy Trial in Adelaide (BMB-101, Placebo)
Recruiting
- Healthy
- BMB-101
- Placebo
-
Adelaide, South Australia, AustraliaCMAX Clinical Research
Aug 8, 2022
Paroxysmal Nocturnal Hemoglobinuria Trial in Adelaide (KP104, Placebo)
Active, not recruiting
- Paroxysmal Nocturnal Hemoglobinuria
- KP104
- Placebo
-
Adelaide, AustraliaCMAX Clinical Research
Aug 4, 2022
Myocardial Infarction Trial in Adelaide (NP-011 (Single Ascending Dose Phase), NP-011 (Multiple Ascending Dose Phase), NP-011
Recruiting
- Myocardial Infarction
- NP-011 (Single Ascending Dose Phase)
- +2 more
-
Adelaide, South Australia, AustraliaCMAX Clinical Research Pty Ltd
Sep 26, 2022
Opiod Use Disorder Trial in Adelaide (Combination Product: Naltrexone)
Recruiting
- Opiod Use Disorder
- Combination Product: Naltrexone
-
Adelaide, South Australia, AustraliaCMAX
Apr 7, 2022